Jasper Therapeutics, Inc. (JSPR): Form 8-K filed 2026-11-04

Items reported

Item 3.03: Material Modifications to Rights of Security Holders
The rights of holders of a class of the company's securities were materially modified, for example by a charter amendment, a rights plan or a reverse stock split.
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year.
Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	CURRENT REPORT	ea0309978-8k_jasper.htm
EX-3.1	CERTIFICATE OF THIRD AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF	ea030997801ex3-1.htm
EX-99.1	PRESS RELEASE, DATED NOVEMBER 4, 2026	ea030997801ex99-1.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.